Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No revs, no cash, lawsuits, what gives?
Next results could blow things wide open!!!
Tic Tok Tic Tok Tic Tok
First and foremost, it’s great news that the drug is already saving the most sick patients from certain death!! And all the other patients in the US and around the world who are very very sick have hope !!
Go RLFTF!!
Dr Javitt is making their results known, why wouldn’t another company. They certainly don’t have to call him personally
But PHAS doesn’t have what Relief has!
Dr Javitt says he isn’t aware of any drug with similar results. And he would know!
Great work!! Thanks!! Please stickie!!
Their drug won’t be reporting phase 2 until “latter 4th quarter” of 2020.
RLFTF will be reporting next week and expects to be in full production by October 2020. With the amount of revenues expected, a $10 bil market cap is likely if they’re not acquired first.
They approved the request in 48 hours when it used to take 6 months.
And I think Dr Javitt gave us a clue of what’s to come when he said his discussions with the FDA are going very well and they approved the inhaled version for trial in 48 hours!
Who cares if it follows Swiss market!! Irrelevant to what’s happening with the company. Waste of everyone’s time
If you have any doubts that Relief has the treatment of choice, if not the cure, for Covid 19 watch the Dr Javitt video posted today, over and over and over and all your doubts will disappear!!
This stock deserves a $10 billion market cap and will be there soon enough!!
Give you one guess?
I know the director only sold 1% of his holdings but his timing couldn’t have been worse! What was he thinking that the stock would go up on the news?
There has been no Phase III trial of the Russian vaccine, but I’m sure you already knew that!
Have a feeling we close green today!
Why won’t they publish the studies?
Something is fishy
How can anyone believe Russia has the vaccine when they won’t publish any studies about it. And it hasn’t even gone through final testing! Ridiculous
I’m talk about the other drug Andy is touting?
Has it been tested on humans?
The guy is probably buying the stock back with the proceeds and making double the profit!
Not like they’re selling hundreds of millions of shares. Maybe the guy had to pay for kids college tuition!
Down 50% in Europe? What’s up?
I don’t know anyone who plans on holding this stock for 3 years.
However, a generic drug can only be marketed after the brand name drug's patent has expired, which may take up to 20 years after the patent holder's drug is first filed with the U.S. Food and Drug Administration (FDA).
Great job...thanks!!
Patience!!
That is not for COVID-19! In any case the drug belongs to Relief
But price target for Novavax was raised to $275 so you’re talking about a 20billion market cap
I don’t think anybody at NeuroRx would compromise study results and risk going to jail!
If the FDA can live with it, so can I!
Although the drug remains under investigation, rapid recovery from respiratory failure in COVID-19 has been seen in patients treated under FDA Emergency Use authorization.1
The expanded access protocol may be viewed on www.clinicaltrials.gov NCT04453839. Physicians who wish to enroll their patients in the protocol must submit the protocol to their local investigational review board and file FDA form 1572 with NeuroRx, Inc. Further information may be obtained from
You can call the FDA tomorrow and find out where it’s listed. Complicated web site
If anything it should be higher! He downplayed it!
What comes across as premature?
What CEO wouldn’t say that when it has already saved lives! You got it backwards, kid!
CEO says 70% chance RLF-100 gets approved for Covid-19. I like those odds!! It’s going to save a lot of lives!!
Will continue accumulating on any dips. I’ll take my chances with Kevin Harrington. He’s a WINNER!!
Sounds like a possible cure to me!!
“No other antiviral agent has demonstrated rapid recovery from viral infection and demonstrated laboratory inhibition of viral replication," said Prof. Jonathan Javitt, CEO and Chairman of NeuroRx. "We are conducting placebo-controlled trials to see whether the observations made in the case-control and open-label studies will be confirmed for less ill patients with COVID-19-related respiratory failure. Our independent Data Monitoring Committee will be conducting an interim analysis of these data later this month."